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Objective: The purpose of this study was to evaluate endovascular treatment in diseases of the descending thoracic aorta.
Material and methods: This study was designed as a single center’s (university hospital) experience. Over a 6-year period
(1995 to 2001), thoracic endografts were placed in 74 patients with a diseased descending thoracic aorta who were at high
risk for conventional open surgical repair: 34 had atherosclerotic aneurysms, six had posttraumatic aneurysms, 14 had
type B dissection with aneurysmal dilatation of the false lumen, 12 had isthmic transections from blunt trauma, five had
thoracoabdominal aneurysms (treated with a combined procedure), two had aortic coarctation, and one had an
aortobronchial fistula. Twenty-six procedures (35.1%) were conducted as emergencies, and 48 (64.9%) were elective. The
feasibility of endovascular treatment and sizing of stent grafts were determined with preoperative spiral computed
tomography and intraoperative angiography.
Results: Endovascular operations were completed successfully in all 74 patients; postprocedural conversion to open repair
was necessary in three cases. The overall 30-day mortality rate was 9.5% (seven deaths). Temporary neurologic deficits
developed in two patients; not one patient had permanent paraplegia. The primary endoleak rate was 20.3% (15 patients).
The mean follow-up period was 22 months (range, 3 to 72 months). Five deaths occurred in the follow-up period, and
three patients needed secondary conversion to open repair 2, 3, and 14 months after initial endografting.
Conclusion: Endoluminal treatment in diseases of the thoracic descending aorta is feasible and may offer results as good
as the open method. (J Vasc Surg 2003;37:91-9.)
Endovascular treatment is considered an evolutionary
step towards less invasive surgical intervention for vascular
diseases. It potentially also represents the alternative mode
of treatment for patients with a diseased descending tho-
racic aorta whose conditions are unfit for open surgery,
mainly because of severe concomitant cardiopulmonary
disease, or who can be managed with conventional surgery
only with a high operative risk.1,2 Endoluminal approach
also appears challenging in the case of rupture of the
descending thoracic aorta (that is, on emergency basis)
because in such patients (ie, patients with multiple trauma)
open surgery is also inhibitive or accompanied by a high
morbidity and mortality rate, despite the improved surgical
techniques, anesthesiologic methods, and sophisticated
dedicated intensive care.3
On the basis of the results of animal studies,4 exclu-
sively performed to investigate the stent grafts’ potential in
achieving functional exclusion of aneurysms and injuries of
the descending thoracic aorta, we wittingly managed pa-
tients with a diseased descending thoracic aorta with the
endoluminal method. This report presents the experience
of a single high-volume center in a 6-year period.
MATERIAL AND METHODS
In 1995, after an institutional decision in agreement by
the national laws, aortic stent grafting was introduced as an
alternative technique to open surgery for the management
of the diseased aorta. In the period between 1995 and
2001, 74 patients (14 women; median age, 65 years; range,
12 to 87 years) with diseases of the descending thoracic
aorta underwent endoluminal treatment. Complete written
informed consent was obtained from all patients or rela-
tives. Forty patients had aneurysmatic disease (mean aneu-
rysm diameter, 69 mm; range, 43 to 107 mm; extension,
16 to 310 mm), 34 patients with atherosclerotic aneurysm
and six with posttraumatic aneurysm of the descending
aorta (Fig 1). Fourteen patients had a chronic type B
dissection with aneurysmal dilatation of the false channel,
with 11 patients undergoing elective repair and three with
acute symptoms (mean false lumen diameter, 68 mm;
range, 45 to 76 mm; Fig 2). Twelve more patients received
immediate stent grafting for descending thoracic (isthmic)
aortic transection from blunt trauma. Five patients with a
thoracoabdominal aortic aneurysm underwent a combined
procedure (ie, a stent-supported exclusion of flow in de-
scending thoracic and abdominal aorta after open transperi-
toneal revascularization of the visceral and renal arteries
from an iliac artery). In addition, one patient with an
aortobronchial fistula and two patients with aortic coarcta-
tion in decompensated heart failure also received stent
grafts. Twenty-six patients (35.1%) underwent emergency
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treatment at the stage of rupture (Fig 3), and the operation
was elective in 48 patients (64.9%; Table).
The feasibility of the endoluminal intervention was
determined with computed tomographic (CT) scan study,
and final sizing was decided with intraoperative angiogra-
phy, with a 10% oversizing in the beginning of the study
that was converted to the current 20%. Most patients
considered at high risk had ASA IV disease, multiple previ-
Fig 1. Preprocedural and predischarge CT scan of atherosclerotic aneurysm of descendig aorta (T3 to T6) in
82-year-old man. Aneurysmal exclusion was achieved with deployment of tube stent graft (TAG Excluder, 40-15,
Gore).
Fig 2. Type B dissection with aneurysmal dilatation of false channel in 59-year-old man. Two thoracic tube stentgrafts
(TAG Excluder, 40-10, 40-20, Gore) have been deployed (T3 to T8) and monitored with transoesophageal
echocardiography.
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Fig 3. A, Preoperative CT scans showing the traumatic descending aortic transection at the isthmic level, mediastinal
hematoma and periaortal bleeding in a polytraumatized 18-year-old man. B, Follow-up CT scans 24 months
poststenting documents complete exclusion of the isthmic aortic transection, no endoleak or signs of infections.
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ous thoracotomies, and trauma with multiple severe inju-
ries. Some patients (30%) with ruptured aortas had a con-
firmative CT scan study from the referring center, and the
rest, if their conditions were hemodynamically controllable,
underwent scanning in our institution (CT scan facility in
the operating room’s section). In the case of an uncontrol-
lable condition, immediate surgical intervention is the rule
in our institution.
The patients who were considered eligible for the en-
dovascular treatment met the following criteria: proximal
neck length, more than 10 mm; diameter, less than 38 mm;
the proximal neck distal to the left common artery (in a
unique case of rupture without proximal neck, the left
common carotid artery also was covered); and existence of
a distal neck length proximal to celiac artery of more than
10 mm. The diameter of the aneurysm or of the aortic
segment with dissection had to be more than 55 mm. Iliac
tortuosity was not considered a contraindication in emer-
gency cases; on the contrary, aortic tortuosity was consid-
ered inhibitive for endoluminal treatment in our institu-
tion. The criteria for intervention in type B aortic
dissections were: presence of ischemic complications, in-
Endovascular treatment in diseases of the descending thoracic aorta
Type
Endo-
vascular
repair
Emerg-
ency
cases
Stent graft
extension
Stent graft
type (cases)
Neurologic
deficit
Hospital
mortality
Complica-
tions
Final treatment
Overstenting Conversion
Aneurysm of
descending
thoracic aorta
34 9 6 patients
LSA-CTr
19 Gore, 1 Distal
dissection
— 1 primary
5 patients
T3-T5
10 Talent, 1 (transient) 1 9 Type I
endoleaks
6 1 secondary
6 patients
T3-T6
2 Corvita, 2*
3 patients
T3-T7
1 Vanguard,
8 patients
T3-T8
1 Stenford,
2 patients
T4-T9
1 AneuRx
4 patients
T7-T12
Acute traumatic
transection of
descending
thoracic aorta
12 12 6 patients
T3-T5
11 Gore — 2† 2 Type I
endoleaks
2
6 patients
T3-T4
1 Talent
Type B dissection 14 3 Variable 12 Gore,
2 Talent
1 (transient) 1 2 Type A
dissections
2 3 primary
1 false lumen
rupture
4 Type
I endoleaks
1 Secondary
endoleak
1 secondary
Posttraumatic
aneurysm of
descending
thoracic aorta
6 T3-T5 4 Gore,
2 Talent
— — — — —
Aortobronchial
fistula
descending
thoracic aorta
1 1 T3-T5 Talent — — Recurrence — 1 secondary
Thoracoabdominal
aneurysm
5 1 2 T6-SA
(juxta)
3 Talent,
2 T6-IA
(juxta)
3 Gore — 2 — —
1 T8-SA
(juxta)
Aortic coarctation 2 — T3-T4 2 Gore — — — — —
Total 74 26 2 8 10 7
*From rupture.
†From concurrent multiple injuries. LSA, Left subclavian artery; AB, aortic Bifurcation; CT, celiac trunk; SA, suprarenal aorta; IA, infrarenal aorta.
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tractable hypertension or uncontrollable pain, an expand-
ing false lumen, and a patent primary entry site.
Self-expanding endografts were implanted exclusively,
and graft diameter varied from 26 to 46 mm. In 47 patients
(63.5%), functional exclusion of the aortic lesion was
achieved with a single stent graft. Two stent grafts were
necessary in 14 patients (18.9%), three in seven patients
(9.5%), four in three patients (4%), and five in two patients
(2.7%).
Preoperative imaging evaluation. The parameters of
the institution’s preoperative spiral CT scan protocol are:
pitch, 0.875; slice thickness, 3.2 mm; and increment, 1.6
mm (caudocranial). CT angiograms were reconstructed at
the local CT workstation. Diameters and aortic segments
were measured in a plane perpendicular to the centerline of
the true aortic lumen. Conventional angiographic images
were obtained in some elective cases (ie, in the dissection
group).
Intraoperative technique. Seventy-three stent-sup-
ported reconstructions were performed with general anes-
thesia, and one with epidural anesthesia. All stent grafts
were implanted with fluoroscopic control with a mobile
C-arm machine and occasional transesophageal echocar-
diographic control (ie, in the dissection group). After sur-
gical exposure, a Terumo guidewire (Terumo, Frankfurt,
Germany) was advanced in most cases through the right
common femoral artery (in two cases through iliac access).
Patients received heparin (5000 IU intravenously). After an
8F sheath insertion over the wire, a 7F pigtail catheter was
advanced into the ascending aorta. Digital subtraction an-
giography was performed with breath-hold technique fol-
lowed by manual injection of 20 mL of nonionic contrast
medium (Iopamidol, Solutrast 300, Byk Gulden, Kon-
stanz, Germany) with the aortic arch turned to about 25
degrees in LAO projection. The adjacent origin of the left
common carotid artery then was marked with a subcutane-
ous needle, and its position was documented on a second
angiogram. The arm position of the fluoroscopy unit then
was frozen to maintain the same exact position and zoom
factor, and a 260-cm Amplatz Superstiff wire (Boston
Scientific, Ratingen, Germany) was inserted, over which
the prosthesis was introduced after exchange of the 8F
access sheath. Without breath holding or the patient’s heart
rate or blood pressure being lowered, the prosthesis was
deployed just distal to the origin of the left common carotid
artery. The pulses in both common carotid arteries then
were checked, and a completion angiogram with breath-
hold technique was obtained in each patient.
Follow-up protocol. Each patient had a spiral CT
scan (Multislice CT unit, Marconi, Cleveland, Ohio) be-
fore discharge and at 3-month and 6-month intervals there-
after to assess the success of the procedure.5 Three-phase
multislice CT scans (slice thickness, 3.2 mm; increment,
1.6 mm [caudocranial]; pitch, 0.875; for unenhanced CT
scan: slice thickness, 6.5 mm; increment, 6.5 mm; pitch,
0.875) were performed in all patients to rule out leaks.
Contrast medium (150 mL, Iopamidol, Solutrast 300, Byk
Gulden, Konstanz, Germany) was applied at a flow rate of
3.5 mL/s with a 25 to 30 second delay. Additional late
images were acquired at 90 seconds (slice thickness, 6.5
mm; increment, 6.5 mm; pitch, 0.875). A multiplanar
reformation of the arterial phase was performed in all cases.
Angiograms were used only in the presence of en-
doleaks on the CT scans and were performed during the
first postoperative week. To rule out graft or wire fracture,
patients underwent radiographic assessment in three planes
at each follow-up interval. In addition, during the first
postoperative week, magnetic resonance imaging studies
were performed in all patients for comparison with the CT
scans. The patients who underwent operation on an emer-
gency basis had an additional early postoperative control
study.
RESULTS
In a 6-year period for a consecutive series of 129
patients with diseases of the descending thoracic aorta, 74
patients (57.4%) were managed with stent grafting. In 73
patients, complete exclusion of the aortic lesion, and more-
over safe cover of the site of rupture in the 12 patients with
acute traumatic transection of the descending aorta, was
achieved with the endovascular approach. None of the 74
patients needed primary intraoperative conversion to open
approach. The mean duration of the procedure was 56
minutes (range, 37 to 215 minutes), the mean fluoroscopy
time was 10 minutes (range, 2 to 42 minutes), and the
mean volume of the contrast agent used was 120 mL
(range, 40 to 350 mL). The mean volume of blood replace-
ment was 150 mL (range, 100 to 3000 mL), and the mean
intensive care unit and hospitalization times were 4 days
(range, 1 to 30 days) and 8 days (range, 4 to 35 days)
respectively. Renal, cardiac, and pulmonary complications
occurred in 12 patients (16.2%). Four patients needed
temporary postoperative hemofiltration. Seven patients had
pulmonary complications develop, and four of these pa-
tients needed mechanical ventilation for more than 24
hours. One patient had a nontransmural myocardial infarc-
tion during hospitalization.
The cumulative 30-day mortality rate was 9.5% (four
emergency and three elective cases; Table), and the hospital
mortality rate was 8.1%. The primary endoleak rate was
20.3% (15 patients). No permanent neurologic deficit was
postoperatively diagnosed in any of the 74 patients. Two
patients had a transient postoperative paraparesis develop
(Table) followed by complete resolution of the deficits.
The mean follow-up period was 22 months (range, 3 to
72 months). Five patients died during the follow-up pe-
riod, with cardiopulmonary events responsible in three
cases. One patient died as a result of the stent-supported
aneurysm exclusion; a ruptured aneurysm of the descend-
ing thoracic aorta was treated with stent grafting with
secondary evacuation of the hemothorax, and the patient
subsequently had a chronic pleural empyema develop,
which ultimately could not be controlled. Another patient
died of cerebral infarction 60 days after stent grafting. No
graft or wire fractures were identified.
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For correct assessment of the thoracic stent graft tech-
nique, it appears useful in reporting the results to distin-
guish between the different pathologic states and the re-
lated general or specific (such as mortality, rate of
conversion and rupture, neurologic deficit, rate of en-
doleak) complications encountered and the additional sur-
gical procedures necessary.
Atherosclerotic and posttraumatic aneurysm of the
descending thoracic aorta. The 30-day mortality rate
was 7.5% (3/40), and the hospital mortality rate was 2.5%
(1/40). One patient who underwent operation on an elec-
tive basis had aortic dissection develop in the visceral seg-
ment of the aorta on the second postoperative day (POD),
after the stent-supported exclusion of an aneurysm of the
descending aorta with partial lower limb paresis and mes-
enteric ischemia; despite the immediate open reconstruc-
tion, the patient died of multiorgan failure on POD 12.
Two more patients died after repair of a ruptured aneurysm
of the descending thoracic aorta; postoperative multiorgan
failure from perioperative shock could not be reversed.
In one case, a technical defect in the implanted first-
generation stent graft was responsible for the impaired
exclusion of a posttraumatic aneurysm. Because there was a
persisting proximal leak, the stent graft was removed and
the first segment of the descending aorta was replaced with
interposition of a Dacron graft 2 months after the initial
operation. Overstenting was not possible at that time be-
cause a comparable stent graft of suitable diameter was not
available.
In nine patients with descending thoracic aortic aneu-
rysms, nine type I endoleaks were detected. In one case, the
endoleak was spontaneously sealed during the first 2 weeks
before discharge. In another case, coil embolization and
overstenting were necessary, and in the remaining six pa-
tients, secondary procedure (overstenting) solved the prob-
lem within 4 postoperative weeks.
Acute traumatic transection. The 30-day mortality
and the hospital mortality rates were 16.6% (2/12). Two
patients were victims of road traffic accidents with multiple
traumas, and in both cases, typical circular traumatic aortic
transection required endovascular emergency treatment.
One patient died 22 days after the accident after an intrac-
table cerebellar edema, and the second patient died 28 days
after the accident of severe abdominal and pelvic injuries.
Both deaths were unrelated to the aortic trauma. In two
patients (16.6%) of this group, a type I endoleak was
revealed. Successful overstenting was performed within the
first week after the initial stent graft deployment.
Dissection type B with aneurysmal dilatation. The
hospital mortality rate was 7% (1/14). In a case of chronic
type B dissection, 10 hours after the elective stent graft
deployment, type A dissection occurred and the patient
underwent immediate open repair with replacement of the
ascending aorta with cardiopulmonary bypass. The bare
springs of the implant (Talent stent graft) used in the initial
operation had provoked the retrograde dissection, and the
patient died of cerebral infarction 60 days after stent graft-
ing.
A secondary endoleak was revealed in another patient
from the chronic type B dissection group; a secondary type
I endoleak developed without evidence of migration of the
deployed stent graft 3 months after the initial endovascular
intervention. This endoleak was sealed with overstenting,
but the bare springs of the stent graft (Talent stent graft)
caused a type A dissection that required the prompt open
replacement of the ascending aorta with cardiopulmonary
bypass.
Open revision on the first POD was necessary in a
patient with an type B dissection with acute picture (rup-
ture in the first segment of the descending aorta). The site
of rupture was initially treated with a stent graft. Open
revision became necessary because of a second acute rup-
ture, this time of the false channel at the thoracoabdominal
segment. Another patient with a type B dissection had a
rupture of the false channel into the left pleural cavity 20
hours after stent graft deployment so that open revision was
needed. One patient of this group had a temporary post-
operative paraparesis develop (Table).
In the type B dissection group, four endoleaks were
detected in four patients. In two patients, the type I en-
doleak was sealed with implanting an additional stent graft
(overstenting), and in another patient, a persistent type I
endoleak required open operation (secondary conversion).
Surveillance was decided in a type II endoleak in a fourth
patient.
Transposition of the left subclavian artery to the left
common carotid artery was performed in one patient in the
dissection group. In another case in the dissection group,
the stent graft was erroneously placed proximal to the left
common carotid artery, and during “pulling back,” the
stent graft failed. Thus, the vascularization of the left com-
mon carotid artery was restored by performing an extraana-
tomic carotid-carotid crossover bypass.
Thoracoabdominal aneurysms. The 30-day mortal-
ity and the hospital mortality rates were 40% (2/5). Two
patients who had undergone the combined approach died
in the first week. The first patient, a 73-year-old man with a
symptomatic aneurysm and severe cormbobidities, died on
the 6th POD of multiorgan failure after ischemic-related
pancreatitis, in spite of the successful combined repair. The
other patient, after having an aortic rupture, underwent
urgent stent grafting and died after multiorgan failure (of
prolonged preoperative shock).
Other. The hospital mortality was nil. Stent grafting
was used for urgent correction of an aortobronchial fistula
and in two cases of aortic coarctation. Fourteen months
after the initial endografting that was used as a “bridging”
means, the patient with the aortobronchial fistula had a
recurrence from a central stent graft migration and required
a secondary conversion to open repair.
Additional operative procedures. A further surgical
procedure was necessary in 11 of 74 patients (14.8%). The
common femoral artery was selected as the access vessel of
first choice with two exceptions. In two patients, the stent
grafts were placed into the thoracic aorta through the
common iliac artery exposed extraperitoneally; both the
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external iliac and the common femoral arteries were unsuit-
able as access vessels in these cases because of arterioscle-
rotic occlusive process. In both these cases, stent graft
placement was followed by disobliteration of the semioc-
cluded external iliac artery or femoral bifurcation, respec-
tively. In two other patients, there was a short segmental
stenosis of the iliac artery that had to be dilated at the same
session before endografting. Two patients had a throm-
botic occlusion develop after surgery in the region of the
access vessels (common femoral artery) because of iatro-
genic dissection; both patients needed transfemoral revi-
sion. A 19-year-old patient with traumatic transection of
the descending thoracic aorta had a rupture of the right
external iliac artery during the withdrawal of the catheter
after the successful stent graft deployment. Vascular spasm
resistant to treatment was apparently responsible for this. In
this patient, the external iliac artery had to be replaced with
an autologous interposition graft.
Transposition of the left subclavian artery to the left
common carotid artery was performed in one patient in the
dissection group and in one in the traumatic aortic transec-
tion group. In one case in the dissection group, the stent
graft was erroneously placed proximal to the left common
carotid artery and during “pulling back,” the stent graft
failed. Thus the vascularization of the left common carotid
artery was restored by performing an extraanatomic carot-
id-carotid crossover bypass.
DISCUSSION
Catheter-based techniques with their theoretic advan-
tages have changed the face of modern vascular surgery.
The minimally invasive character of stent grafting with the
obvious avoidance of major surgery and aortic cross clamp-
ing in the case of a diseased descending thoracic aorta is
challenging, although long-term results are unknown.6,7
For certain groups of patients at high risk with severe
concomitant diseases, for patients with previous multiop-
erations, and for patients with multiple traumas, the en-
doluminal method might offer the alternative solution in-
stead of a frustrated open procedure, although again the
successful outcome would by no means be totally ensured
because, as with every surgical procedure, endoluminal
interventions are also accompanied by complications.8-11
The method is under continuous development, and the
experience, including the complications of different cen-
ters, has to be detailed so the limitations of the method will
be enlightened. Endoleak is a specific method-related com-
plication of thoracic aortic endografting. Although in the
initial steps of our study endoleaks in the thorax seemed
markedly less significant because of their low incidence rate
and the possibility of simple correction in relation to stent-
supported exclusion of aneurysms of the infrarenal aorta, it
soon became obvious that endoleaks after thoracic endo-
vascular therapy are a serious complication reaching the
infrarenal frequence. In this series, the primary endoleak
rate was 20.35% (15 patients) and the secondary endoleak
rate was 1.3% (one patient). Apart from the admittedly
existent learning curve of our team, other reasons for this
endoleak rate were the type of stent grafts we used (we now
use flexible stent grafts) and the initial short neck length.
After the observation of the high endoleak incidence rate,
we changed the criteria for the proximal neck length. We
now suggest, after the complications encountered, that the
inner curve neck should have a length of at least 20 mm. To
extend the neck length, we follow the policy to cover the
left subclavian artery. Although in one case we erroneously
covered the left common artery, we suggest that the prox-
imal landing zone has to be distal to the left common
artery.
Stent grafting in elective cases can always be performed
with hemodynamically stable conditions and without long
aortic cross clamping (only two to three intervals of aortic
cross clamping of 15 seconds each are necessary for the
stent graft modeling). Therefore, at least two potential risk
factors theoretically responsible for the neurologic deficit
are absent in thoracic endografting. Moreover, the absence
of topical trauma with the subsequent avoidance of the
iatrogenic damage of the collateral circulation might be an
additional reason for the markedly lower rate of paraplegia
in comparison with the open repair, although intercostal
artery revascularization is impossible in this setting. In our
group of patients, there was no case of permanent neuro-
logic deficit and only a temporary paresis, mainly affecting
the lower limbs, was observed in two patients. In the
Stanford group, which has the largest number of patients,
there were only three cases (2.9%) of paraplegia in 103
patients treated with thoracic stent grafting.11 Mapping of
stent graft extension in different patients may help to
identify risk zones that have to be avoided in stent grafting.
The stent graft extension in this series is provided in Table.
The endoluminal method offers an invaluable advan-
tage, especially in the emergency situation. Depending on
patient selection, the mortality rate in those patients with
acute aortic rupture increases sharply with the conventional
open repair. Although the mortality rate among our pa-
tients was 29.9% with conventional open surgery of rup-
tured aneurysms of the descending aorta and 57.1% in the
case of ruptured thoracoabdominal aneurysm, the inci-
dence rate was about 15% in the stent graft group (four
deaths in 26 emergency procedures); however, no direct
comparison between the two groups should be made. It is
reasonable to consider the endoluminal mode of treatment
for certain groups of patients, like the elderly with comor-
bidities who reach a tertiary center with their ruptured
aneurysm (in most cases in shock), especially when the
elective open surgery for their thoracic aneurysm had al-
ready been refused by many centers. In this series, there was
an initial hesitation in relation to the endovascular interven-
tion on acute setting because of the lack of available stent
grafts. After an administrative regulation, stent grafts were
“on shelf” in our institution, and the hospital soon became
a referral center for elective and trauma patients.
The status and acceptance of the thoracic stent grafting
are largely determined by whether a long-term achievement
of functional exclusion of the aneurysm or secure seal of the
site of rupture can be accomplished with this approach.
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Apart from mortality, this objective is determined above
all by the rate of rupture after stent graft placement
(secondary rupture) and by the rate of conversion to the
conventional open repair. Isolated cases of secondary
rupture after stent grafting have been described in many
reports.12,13 In all of these cases, technical errors of
untreated primary or secondary endoleaks could be in-
criminated. Similarly, the rate of conversion correlates
with the experience and learning curve of the research-
ers, the quality of the operative diagnostic investigations,
and patient selection.14 In this series of patients, the rate
of postprocedural conversion to open repair was 4%
(three patients) and the rate of secondary conversion was
2.7% (two patients). After the unfortunate outcome in
the case of the patient with the aneurysm who underwent
the open conversion (see Results), we presume that the
tortous aorta is a contraindication for endoluminal inter-
vention. Greenberg et al12 published a similar case with a
tortuous aorta and massive distal embolization. In our
case, the manipulations for the passage of the introducer
probably caused the distal dissection that was manifested
on POD 2. Other threatening complications were the
two type A dissections created by the manipulation of the
stent graft in the aortic arch. In both cases of type A
dissection, perforation of the intimal and medial layer of
the aortic wall by the bare springs of the stent graft had
occurred. Open repair including replacement of the as-
cending aorta was necessary. Uncontrolled movement
during the procedure to release the stent graft (there was
kinking of the introduction device in the aortic arch)
caused the injury of the friable aortic wall by the bare
spring of the partially exposed stent graft. The bare
spring type of the Talent stent graft is therefore no
longer placed in the proximal end in our department.
This type of complication has already been desribed15
and recently again was described after use of a Gore
Excluder stent graft.16 Another absolute contraindica-
tion in our protocol suggested by our complications is
the coverage of the celiac trunk. In the patient with the
thoracoabdominal aneurysm, the occlusion of the celiac
artery by the stent graft presumably resulted in ischemic
pancreatitis.
A further specificity of the endovascular procedure is
the necessity for additional operative procedures or inter-
ventions. In our patients, the most frequent was the oper-
ative revision in the region of the access vessels, such as the
correction of central obstruction of flow or operative cor-
rection of dissections or thrombotic occlusions in the groin
vessels. If the stent graft is placed proximal to the left
subclavian artery, transposition of the left subclavian artery
to the left carotid artery might be necessary in a few cases.
Additional surgical procedures were needed in 10 of our 74
patients (13.5%).
In this series, the most complications were observed
after treatment of type B dissection. Retrograde dissection,
type A dissection, endoleaks, conversion to open surgery,
and paraparesis occurred in this group. This not strange as
dissection presents inherent problems with primarily the
difficulty to access the extension of the dissection and in
particular the entry site of the dissection. Three-dimen-
sional CT scan is indispensable in this. All leakages in this
group were found to be close to the inner arch, probably
from the lower radial force at the inner curve. Oversizing by
6 to 8 mm is the solution, as is extension of the neck length,
and overstenting of the left subclavian artery is not a con-
traindication. However, we found no (endoleak) reperfu-
sion of the false lumen via the left subclavian artery.
In conclusion, our results show that endovascular
treatment in different types of aortic disease of the
descending thoracic aorta is technically feasible, and this
method of treatment is also associated with a similar
safety for the patient as the open procedure, with respect
to the limitations already mentioned. From the anatomic
viewpoint, it seems that this method can be used in
nearly every second patient (57.3%) in whom treatment
of an atherosclerotic, posttraumatic, or dissection-in-
duced aneurysm of the descending thoracic aorta or an
acute traumatic rupture of the aorta is indicated. Al-
though the long-term reliability of stent grafts is under
question, these catheter-based techniques potentially of-
fer an alternative mode of management for diseases of
the descending thoracic aorta. However, although the
method seems simple, an experienced team is required
both for the preoperative assessment and for the intra-
operative manipulation. This is cardinal, in particular for
certain severe types of thoracic aortic disease, such as the
type B dissections.17,18 Specific complications, such as
endoleaks, or additional procedures cannot be avoided
completely. A reduction in these method-related com-
plications can in all probability be achieved only by
improved stent grafts10 and optimal patient selection and
matching.2
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